Synthesis of (-)-[4-3H]epigallocatechin gallate and its metabolic fate in rats after intravenous administration

被引:93
作者
Kohri, T
Nanjo, F
Suziki, M
Seto, R
Matsumoto, N
Yamakawa, M
Hojo, H
Hara, Y
Desai, D
Amin, S
Conaway, CC
Chung, FL
机构
[1] Mitsui Norin Co Ltd, Food Res Labs, Fujieda City, Shizuoka 4260133, Japan
[2] Amer Hlth Fdn, Div Organ Synth Facil & Carcinogenesis & Mol Epid, Valhalla, NY 10595 USA
关键词
(-)-epigallocatechin gallate; (-)-[4-H-3]epigallocatechin gallate; catechin; tea; biliary excretion;
D O I
10.1021/jf0011236
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
Because a great deal of attention has been focused on the metabolism of (-)-epigallocatechin gallate (EGCg), quantitative analysis of this compound is required. For this purpose we developed a method of chemical synthesis of [4-H-3]EGCg. Synthesized [4-H-3]EGCg showed 99.5% radiochemical purity and a specific activity of 13 Ci/mmol. To clarify the excretion route of EGCg, the radioactivity levels of bile and urine were quantified after intravenous administration of [4-H-3]EGCg to bile-duct-cannulated rats. Results showed that the radioactivity of the bile sample excreted within 48 h accounted for 77.0% of the dose, whereas only 2.0% of the dose was recovered in the urine. The excretion ratio of bile to urine was calculated to be about 97:3. These results clearly showed that bile was the major excretion route of EGCg. Time-course analysis of the radioactivity in blood was also performed to estimate the pharmacokinetic parameters following intravenous administration of [4-H-3]EGCg. In addition, EGCg metabolites excreted in the bile within 4 h after the intravenous dose of [4-H-3]EGCg were analyzed by HPLC. The results showed that 4',4"-di-O-methyl-EGCg was present in the conjugated form and made up about 14.7% of the administered radioactivity.
引用
收藏
页码:1042 / 1048
页数:7
相关论文
共 23 条
[1]  
BULLES H, 1975, ARZNEIMITTEL-FORSCH, V25, P902
[2]  
Chen LS, 1997, DRUG METAB DISPOS, V25, P1045
[3]  
CHISAKA T, 1988, CHEM PHARM BULL, V36, P227
[4]   ANTIBACTERIAL ACTIVITY OF TEA POLYPHENOLS AGAINST PHYTOPATHOGENIC BACTERIA [J].
FUKAI, K ;
ISHIGAMI, T ;
HARA, Y .
AGRICULTURAL AND BIOLOGICAL CHEMISTRY, 1991, 55 (07) :1895-1897
[5]   Identification of biliary metabolites of (-)-epigallocatechin gallate in rats [J].
Kida, K ;
Suzuki, M ;
Matsumoto, N ;
Nanjo, F ;
Hara, Y .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2000, 48 (09) :4151-4155
[6]  
LEE MJ, 1995, CANCER EPIDEM BIOMAR, V4, P393
[7]   REDUCTION OF BLOOD-GLUCOSE LEVELS BY TEA CATECHIN [J].
MATSUMOTO, N ;
ISHIGAKI, F ;
ISHIGAKI, A ;
IWASHINA, H ;
HARA, Y .
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 1993, 57 (04) :525-527
[8]   Inhibitory effects of tea catechins, black tea extract and oolong tea extract on hepatocarcinogenesis in rat [J].
Matsumoto, N ;
Kohri, T ;
Okushio, K ;
Hara, Y .
JAPANESE JOURNAL OF CANCER RESEARCH, 1996, 87 (10) :1034-1038
[9]   ANTIOXIDATIVE ACTIVITY OF TEA LEAF CATECHINS [J].
MATSUZAKI, T ;
HARA, Y .
JOURNAL OF THE AGRICULTURAL CHEMICAL SOCIETY OF JAPAN, 1985, 59 (02) :129-134
[10]   BILIARY EXCRETION OF FOREIGN COMPOUNDS - BIPHENYL STILBOESTROL AND PHENOLPHTHALEIN IN RAT - MOLECULAR WEIGHT POLARITY AND METABOLISM AS FACTORS IN BILIARY EXCRETION [J].
MILLBURN, P ;
SMITH, RL ;
WILLIAMS, RT .
BIOCHEMICAL JOURNAL, 1967, 105 (03) :1275-&